Yuko Nitahara‐Kasahara

1.2k total citations
35 papers, 876 citations indexed

About

Yuko Nitahara‐Kasahara is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Yuko Nitahara‐Kasahara has authored 35 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Genetics and 11 papers in Genetics. Recurrent topics in Yuko Nitahara‐Kasahara's work include Muscle Physiology and Disorders (13 papers), Mesenchymal stem cell research (10 papers) and Virus-based gene therapy research (6 papers). Yuko Nitahara‐Kasahara is often cited by papers focused on Muscle Physiology and Disorders (13 papers), Mesenchymal stem cell research (10 papers) and Virus-based gene therapy research (6 papers). Yuko Nitahara‐Kasahara collaborates with scholars based in Japan, Switzerland and United States. Yuko Nitahara‐Kasahara's co-authors include Takashi Okada, Shin’ichi Takeda, Hiromi Hayashita‐Kinoh, Masakazu Kamata, Yoko Aida, Hironori Okada, Aki Nakamura-Takahashi, Chikako Nito, Kazumi Kimura and Yoichi Miyamoto and has published in prestigious journals such as PLoS ONE, Journal of Virology and Human Molecular Genetics.

In The Last Decade

Yuko Nitahara‐Kasahara

35 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Nitahara‐Kasahara Japan 19 540 206 205 133 127 35 876
Julie Dumonceaux France 20 1.1k 2.1× 121 0.6× 289 1.4× 126 0.9× 185 1.5× 47 1.4k
Georgia Barlovatz‐Meimon France 21 590 1.1× 54 0.3× 81 0.4× 134 1.0× 60 0.5× 34 1.2k
Emilie Besnard France 9 872 1.6× 60 0.3× 54 0.3× 52 0.4× 155 1.2× 10 1.1k
Levent Akyüz Germany 11 459 0.8× 143 0.7× 151 0.7× 136 1.0× 19 0.1× 19 901
Claude Bagnis France 21 822 1.5× 317 1.5× 318 1.6× 283 2.1× 21 0.2× 52 1.5k
Hideki Hanawa Japan 20 1.3k 2.3× 1.2k 5.8× 278 1.4× 68 0.5× 61 0.5× 38 1.9k
Jon Meyer United States 5 1.0k 1.9× 117 0.6× 65 0.3× 32 0.2× 195 1.5× 6 1.2k
Michael V. Gonzalez United States 15 275 0.5× 54 0.3× 44 0.2× 62 0.5× 43 0.3× 42 701
William Coley United States 14 532 1.0× 53 0.3× 41 0.2× 52 0.4× 58 0.5× 16 766
Valeriu B. Cismasiu Romania 12 530 1.0× 60 0.3× 47 0.2× 186 1.4× 32 0.3× 13 937

Countries citing papers authored by Yuko Nitahara‐Kasahara

Since Specialization
Citations

This map shows the geographic impact of Yuko Nitahara‐Kasahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Nitahara‐Kasahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Nitahara‐Kasahara more than expected).

Fields of papers citing papers by Yuko Nitahara‐Kasahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Nitahara‐Kasahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Nitahara‐Kasahara. The network helps show where Yuko Nitahara‐Kasahara may publish in the future.

Co-authorship network of co-authors of Yuko Nitahara‐Kasahara

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Nitahara‐Kasahara. A scholar is included among the top collaborators of Yuko Nitahara‐Kasahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Nitahara‐Kasahara. Yuko Nitahara‐Kasahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsunekawa, Yuji, et al.. (2024). Purification of Adeno‐Associated Viral Vector Serotype 9 Using Ceramic Hydroxyapatite Chromatography and its Analysis. Current Protocols. 4(6). e1068–e1068. 1 indexed citations
2.
Sakamoto, Yuki, Yoshitaka Miyagawa, Chikako Nito, et al.. (2023). iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress. Molecular Therapy — Methods & Clinical Development. 30. 333–349. 10 indexed citations
3.
Mizumoto, Shuji, Yuko Nitahara‐Kasahara, Takahiro Yoshizawa, et al.. (2023). Collagen Network Formation in In Vitro Models of Musculocontractural Ehlers–Danlos Syndrome. Genes. 14(2). 308–308. 3 indexed citations
4.
Tsunekawa, Yuji, Takako Sasaki, Kenji Sakamoto, et al.. (2023). Development of a novel purification method for AAV vectors using tangential flow filtration. Biotechnology and Bioengineering. 120(11). 3311–3321. 12 indexed citations
5.
Nitahara‐Kasahara, Yuko, et al.. (2023). Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy. Stem Cell Research & Therapy. 14(1). 108–108. 5 indexed citations
6.
Nitahara‐Kasahara, Yuko, Mutsuki Kuraoka, Guillermo Posadas-Herrera, et al.. (2021). Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy. Stem Cell Research & Therapy. 12(1). 78–78. 7 indexed citations
7.
Nitahara‐Kasahara, Yuko, Guillermo Posadas-Herrera, Shuji Mizumoto, et al.. (2021). Myopathy Associated With Dermatan Sulfate-Deficient Decorin and Myostatin in Musculocontractural Ehlers-Danlos Syndrome: A Mouse Model Investigation. Frontiers in Cell and Developmental Biology. 9. 695021–695021. 8 indexed citations
8.
Nitahara‐Kasahara, Yuko, Mutsuki Kuraoka, Yuki Oda, et al.. (2021). Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy. Stem Cell Research & Therapy. 12(1). 105–105. 25 indexed citations
9.
Yoshizawa, Takahiro, Yuko Nitahara‐Kasahara, Takashi Okada, et al.. (2020). Backcrossing to an appropriate genetic background improves the birth rate of carbohydrate sulfotransferase 14 gene-deleted mice. EXPERIMENTAL ANIMALS. 69(4). 407–413. 4 indexed citations
10.
Hayashita‐Kinoh, Hiromi, Guillermo Posadas-Herrera, Yuko Nitahara‐Kasahara, et al.. (2020). Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment. Molecular Therapy — Methods & Clinical Development. 20. 133–141. 7 indexed citations
11.
Kuraoka, Mutsuki, Yuko Nitahara‐Kasahara, Hisateru Tachimori, et al.. (2018). Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs. PLoS ONE. 13(12). e0208415–e0208415. 7 indexed citations
12.
Tanihata, Jun, et al.. (2017). Low-Intensity Training and the C5a Complement Antagonist NOX-D21 Rescue the mdx Phenotype through Modulation of Inflammation. American Journal Of Pathology. 187(5). 1147–1161. 21 indexed citations
13.
Nakajima, Masataka, Chikako Nito, Satoshi Suda, et al.. (2017). Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke. Molecular Therapy — Methods & Clinical Development. 6. 102–111. 117 indexed citations
14.
Nakamura-Takahashi, Aki, Koichi Miyake, Atsushi Watanabe, et al.. (2016). Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector. Molecular Therapy — Methods & Clinical Development. 3. 15059–15059. 21 indexed citations
15.
Nitahara‐Kasahara, Yuko, Shin’ichi Takeda, & Takashi Okada. (2016). Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflammation and Regeneration. 36(1). 14–14. 24 indexed citations
16.
Hayashita‐Kinoh, Hiromi, Hironori Okada, Yuko Nitahara‐Kasahara, et al.. (2015). Intra-Amniotic rAAV-Mediated Microdystrophin Gene Transfer Improves Canine X-Linked Muscular Dystrophy and May Induce Immune Tolerance. Molecular Therapy. 23(4). 627–637. 25 indexed citations
17.
Nitahara‐Kasahara, Yuko, Hiromi Hayashita‐Kinoh, Tomoko Chiyo, et al.. (2013). Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Human Molecular Genetics. 23(15). 3990–4000. 39 indexed citations
18.
Nitahara‐Kasahara, Yuko, Hiromi Hayashita‐Kinoh, Hironori Okada, et al.. (2011). Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy. Molecular Therapy. 20(1). 168–177. 41 indexed citations
19.
Okada, Takashi, Mutsuko Nonaka‐Sarukawa, Ryosuke Uchibori, et al.. (2009). Scalable Purification of Adeno-associated Virus Serotype 1 (AAV1) and AAV8 Vectors, Using Dual Ion-Exchange Adsorptive Membranes. Human Gene Therapy. 20(9). 1013–1021. 91 indexed citations
20.
Nitahara‐Kasahara, Yuko, Masayoshi Fukasawa, Fumiko Shinkai‐Ouchi, et al.. (2008). Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. Virology. 383(2). 319–327. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Dumonceaux Breakdown of academic impact, for papers by Georgia Barlovatz‐Meimon Breakdown of academic impact, for papers by Emilie Besnard Breakdown of academic impact, for papers by Levent Akyüz Breakdown of academic impact, for papers by Claude Bagnis Breakdown of academic impact, for papers by Hideki Hanawa Breakdown of academic impact, for papers by Jon Meyer Breakdown of academic impact, for papers by Michael V. Gonzalez Breakdown of academic impact, for papers by William Coley Breakdown of academic impact, for papers by Valeriu B. Cismasiu
Rankless by CCL
2026